Gilead Sciences Confirms Breakthrough In Anti-COVID Drug Remdesivir

In a critical announcement that brings hope to millions around the world, Gilead Sciences, which is in the midst of critical Phase 3 trials of the drug Remdesivir in coronavirus patients, said that a breakthrough has been achieved. In Left, Right and Centre, we speak to Dr. Syra Madad, a Pathogens Expert on the reliability of this drug and whether this drug is the cure the world is looking for. We also speak to KT Rama Rao, the working President of TRS, on how Telangana is fighting the highly contagious coronavirus.